This inventor holds 1 USPTO granted patent. Top assignee: Texas A&M University System. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Arthritis Treatment by James K. Carrow
Introduction
James K. Carrow is an innovative inventor based in College Station, TX (US). He has made significant contributions to the field of medical technology, particularly in the treatment of arthritis. His work focuses on the development of mineral-based nanoparticles that have the potential to transform arthritis treatment.
Latest Patents
James K. Carrow holds a patent for "Mineral-based nanoparticles for arthritis treatment." This invention involves mineral-based nanoparticles comprising silicate nanoparticles that induce human mesenchymal stem cells (hMSCs) into a cartilage-lineage. This process is achieved through the upregulation of cartilage-specific genes, resulting in the transformation of the cell phenotype into that of a chondrocyte, which is a cartilage-producing cell. The silicate nanoparticles are synthesized through a process where the precipitate of sodium silicate is mixed with one or more elements and compounds and milled into nanoparticles. He has 1 patent to his name.
Career Highlights
James K. Carrow is affiliated with the Texas A&M University System, where he conducts research and develops innovative solutions in the field of biomedical engineering. His work has garnered attention for its potential impact on treating degenerative diseases such as arthritis.
Collaborations
James collaborates with Akhilesh K. Gaharwar, who is also involved in research related to advanced materials and their applications in medicine.
Conclusion
James K. Carrow's innovative work in developing mineral-based nanoparticles represents a significant advancement in arthritis treatment. His contributions to the field highlight the importance of research and innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile